MD-PhD Grad Named MIT TR35

Gilad Evrony recognized as pioneer in biotech and medicine

Gilad Evrony. Image: James Bareham​Gilad Evrony, a recent graduate of the Harvard/MIT MD-PhD Program, has been named one of the MIT Technology Review Innovators Under 35.

Evrony is being recognized as a pioneer in the field of biotechnology and medicine for his work done while at HMS.

Evrony is currently at Mount Sinai Hospital in New York City for a pediatrics internship and will be returning to HMS and Massachusetts General Hospital for a research and neurology residency after his internship.

“I looked up to the awardees of the TR35 as role models because I've always believed in the power of new technologies to drive innovation in science,” Evrony said. “So it's wonderful to be recognized by an award dedicated to technology innovation.”

Bullard Professor of Pediatrics and Neurology Christopher A. Walsh, described Evrony as “indefatigable, artistic and multi-talented.”

Winners of the Innovators Under 35 will give a brief stage presentation of their work and will be honored at the annual EmTech MIT conference Nov. 2-4 at the MIT Media Lab in Cambridge, Mass.

Winners will be profiled in the September/October issue of MIT Technology Review.

Since 1999, MIT has selected young innovators whose work they believe has the greatest potential to transform the world. Each year, award winners are nominated either by the public or by MIT Technology Review’s editors. The awards cover fields such as biotechnology, materials, computer hardware, energy, transportation, communications and the web.